<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Advanced therapeutic product licence</p><ul class="Section ProvisionList" id="1174058"><li><p class="Subsection" id="1174060"><strong><a class="sectionLabel" id="s-21.92"><span class="sectionLabel">21.92</span></a></strong> <span class="lawlabel">(1)</span> Subject to the regulations, the Minister may, on application, issue or amend an advanced therapeutic product licence that authorizes a person to import, sell, advertise, manufacture, prepare, preserve, package, label, store or test an advanced therapeutic product if the Minister believes that the applicant has provided sufficient evidence to support the conclusion that</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174061"><span class="lawlabel">(a)</span> the benefits associated with the product outweigh the risks; and</p></li><li><p class="Paragraph" id="1174062"><span class="lawlabel">(b)</span> the risks associated with the product and the activity will be adequately managed and controlled.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Application</p><p class="Subsection" id="1174063"><span class="lawlabel">(2)</span> An application for an advanced therapeutic product licence, or for its amendment, shall be filed with the Minister in the form and manner specified by the Minister and shall set out the information required by the Minister as well as any prescribed information.</p></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Terms and conditions</p><p class="Subsection" id="1174065"><span class="lawlabel">(3)</span> The Minister may impose terms and conditions on an advanced therapeutic product licence, including an existing licence, or amend them.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">2019, c. 29, s. 169</li></ul></div>